Connecticut 2013 Regular Session

Connecticut House Bill HB05906

Introduced
1/24/13  
Introduced
1/24/13  
Refer
1/24/13  
Refer
1/24/13  
Refer
3/7/13  
Refer
3/7/13  
Report Pass
3/12/13  
Report Pass
3/12/13  
Refer
3/25/13  
Refer
3/25/13  

Caption

An Act Concerning Prescriptions For Controlled Substances And Use Of The Connecticut Prescription Monitoring And Reporting System.

Impact

The passed legislation amends existing statutes concerning the distribution and prescribing of medications. Specifically, it enhances the regulatory framework governing healthcare providers by incorporating mandatory checks into the prescription process. This change is anticipated to improve patient safety and health outcomes by ensuring that clinicians have access to a patient's complete medication history, thereby reducing the risks associated with drug abuse. Additionally, the bill's enactment reflects a larger trend toward stricter regulations on opioids and other controlled substances to combat the pervasive issue of addiction and overdose.

Summary

House Bill 5906, titled 'An Act Concerning Prescriptions for Controlled Substances and Use of the Connecticut Prescription Monitoring and Reporting System', was introduced to enhance the regulation and oversight of controlled substances within the state of Connecticut. The bill mandates that practitioners who dispense or prescribe controlled substances must obtain a certificate of registration and review a patient's prescription history through an established electronic monitoring program before proceeding with any prescription. This aim is to prevent misuse and over-prescription of controlled substances, which is a growing concern in many states, including Connecticut.

Sentiment

The general sentiment surrounding HB 5906 appears to be positive among healthcare providers and advocacy groups concerned with public health. Supporters argue that the bill is a necessary step in combatting prescription drug abuse and ensuring responsible prescribing practices. However, there may also be some concerns among practitioners regarding the implications of increased regulatory oversight and the additional administrative burdens it could impose on their practice. Overall, the focus of the sentiment reflects a collective desire to address the opioid crisis and enhance the safety of prescription practices.

Contention

Points of contention related to HB 5906 primarily revolve around the operational implications for healthcare practitioners and potential unintended consequences of increased regulations. Some critics may argue that while the bill's intentions are noble, the requirements might complicate the prescribing process, potentially delaying access to necessary medications for patients in need. Balancing the need for regulation with the necessity for timely patient care will be crucial as the bill is implemented.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.